AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Remuneration Information Feb 11, 2021

4924_dirs_2021-02-11_421668a6-4beb-497a-ba9e-1bed1748e8c0.html

Remuneration Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 8592O

Assura PLC

11 February 2021

11 February 2021

Assura plc

Exercise of Nil Cost Options under PSP

Assura plc ("Assura"), the leading primary care property investor and developer announces that on 9 February 2021, Jayne Cottam exercised her 2017 PSP awards.

The table below shows the number of shares vesting to Mrs Cottam, the number of shares sold to satisfy income tax and national insurance liabilities, the number of shares received following the sale and the resultant shareholding of Ms Cottam and her persons closely associated ("PCAs").

Number of

Shares awarded
Number of shares sold to satisfy income tax and national insurance liabilities Shares retained Shareholding of PDMR and PCAs post exercise
Jayne Cottam (CFO) 167,681 (78,810) 88,871 266,537

The Remuneration Committee of Assura had agreed that sufficient shares may be sold by PDMRs to cover the arising income tax and national insurance liabilities. The relevant market price for taxation purposes is £0.7376 per share.

Following the allotment, Mrs Cottam transferred 88,871 shares to her husband. The total beneficial holding of Ms Cottam and her PCAs remains the same.

The Notification of Dealing Form for the PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jayne Cottam

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/ Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Assura plc

b)

LEI

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Vesting of share awards under PSP

c)

Price(s) and volume(s)

Price(s) Volume(s)
£NIL GBP 167,681

d)

Aggregated information

-      Aggregated volume

-    Price

N/A

e)

Date of the transaction

9 February 2021

f)

Place of the transaction

XLON

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Sale of 78,810 shares to satisfy tax and national insurance liabilities.

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.7376 GBP 78,810

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price Aggregate Volume Aggregate Total
£0.7376 GBP 78,810 £58,130.25

e)

Date of the transaction

10 February 2021

f)

Place of the transaction

XLON

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 10 pence each

GB00BVGBWW93

b)

Nature of the transaction

Transfer of 88,871 shares to Mrs Cottam's husband.

c)

Price(s) and volume(s)

Price(s) Volume(s)
£0.7376 GBP 88,871

d)

Aggregated information

-      Aggregated volume

-    Price

Aggregate Price Aggregate Volume Aggregate Total
£0.7376 GBP 88,871 £65,551.25

e)

Date of the transaction

10 February 2021

f)

Place of the transaction

XLON

- Ends -

For more information, please contact:

Assura plc

Orla Ball, Company SecretaryDavid Purcell, Head of Investor Relations
Tel: 01925 420680

Email: [email protected]
Finsbury

Gordon Simpson

James Thompson
Tel: 0207 251 3801

Email: [email protected]

Notes to Editors

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2020, Assura's property portfolio was valued at £2,259 million.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association.

Assura plc LEI code: 21380026T19N2Y52XF72

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHGPUWPPUPGGQG

Talk to a Data Expert

Have a question? We'll get back to you promptly.